Log in to save to my catalogue

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_46a09b637dfb42aab34016e0737a3bb6

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation

About this item

Full title

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2018-01, Vol.9 (1), p.374-17, Article 374

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

Subjects and topics

More information

Scope and Contents

Contents

AMP-activated protein kinase (AMPK) has been shown to inhibit cardiac hypertrophy. Here, we show that submaximal AMPK activation blocks cardiomyocyte hypertrophy without affecting downstream targets previously suggested to be involved, such as p70 ribosomal S6 protein kinase, calcineurin/nuclear factor of activated T cells (NFAT) and extracellular...

Alternative Titles

Full title

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_46a09b637dfb42aab34016e0737a3bb6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_46a09b637dfb42aab34016e0737a3bb6

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-02795-4

How to access this item